SAB-Y19

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameSAB-Y19

Drug Alias NameSAB-Y19

ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionEphrin type-A receptor 2 modulators

TargetsEphrin type-A receptor 2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSyntab Therapeutics Gmbh

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSyntab Therapeutics Gmbh

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A